Article Abstract:
ClubLink Corp. of King City, in Ontario, Canada, has completed the acquisition of land in Muskoka near Toronto, in Ontario, Canada. This will permit ClubLink to produce five new resort golf courses there. ClubLink president and chief executive officer Bruce Simmonds noted that the sport of golf is turning into the basic feature for marketing high-end resorts, particularly for corporate conferences. ClubLink has been collaborating with GolfSouth LLC of Greenville, SC, to identify new properties in the Carolinas and the mid-Atlantic states to develop into golf courses.
Comment:
Has been collaborating with ClubLink Corp. to identify new properties in Carolinas and mid-Atlantic states
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
Mississauga, Ontario-based Draxis Health Inc. founder Morton Shulman seeks his share of the US$41-million deal between Draxis and Pfizer Animal Health Inc., a unit of New York-based Pfizer Inc. The agreement allows Pfizer to market Anipryl, a drug used to treat neurological disorders such as excessive thirst, frequent urination and senility in dogs. Along with Hungarian pharmacologist Jozsef Knoll, Shulman claims he is a co-inventor of Anipryl, which is awaiting approval from the US Food and Drug Administration. Draxis is the former Deprenyl Research Ltd.
Comment:
Founder Morton Shulman seeks his share of the US$41-mil deal between Draxis and Pfizer Animal Health Inc, a unit of Pfizer
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
Ontario-based Med-Chem Health Care Ltd expects that it will be granted a receivership on Feb 1, 1999, a move that will allow the sale of its medical laboratory operations. The company has had problems since late 1998 in restructuring a debt of $82 million to meet bankruptcy court requirements under the Companies' Creditors Arrangement Act that would have given clearance to continue operations as a smaller business.
User Contributions:
Comment about this article or add new information about this topic: